Mental Health Clinician Volume 2: Issue 10

Select Issue

Pharmacist graduation competencies in a transformed healthcare market – Implications for psychiatric pharmacy

PharmD, FCCP, BCPP

Substantial progress has occurred in psychiatric pharmacy education since Fred Elmadjain, in his role as a pharmacist/psychopharmacologist at NIMH, advocated for colleges of pharmacy to get interested in mental health during the 1960s and when Glen Stimmel created his own psychiatric pharmacy rotation at UCSF in 1971.¹ Psychiatric pharmacy has grown as a specialty to include 758 board certified psychiatric pharmacists and nearly 40 psychiatric pharmacy residency programs. Yet, much is left to be accomplished. We do not have the necessary critical mass of psychiatric pharmacists to transform pharmacotherapy care for mentally ill individuals, and we must graduate

Download PDF

Toolbox: Tips for writing multiple choice questions

PharmD, BCPS, BCPP

DOI: 10.9740/mhc.n143930

Have you ever watched a room full of students taking a multiple choice exam? I have, many times. I have watched students as they grumble, look up at the ceiling, groan, and squirm in their seats. I have even seen some cry. Multiple choice (MC) questions – student hate them and faculty are not comfortable writing them. Students thought my questions were too difficult, vague, or confusing. Of course, I felt differently about those multiple choice questions. I thought the questions were clear, concise, and fairly met every objective I asked the students to know. What could have possibly gone

Download PDF

Movies and mental illness: A psychiatry elective for third year pharmacy students

PharmD, BCPP, FASHP

DOI: 10.9740/mhc.n143595

Psychiatric illnesses are common and pharmacists need to be able to recognize the signs and symptoms of the illnesses and know how they are appropriately treated. Not all pharmacy students will have an opportunity to intern in a psychiatric setting during their fourth year, and there is not adequate time in the course of a problem based learning (PBL) therapeutics curriculum to teach many of the psychiatric illnesses and their treatment. This article describes an elective course in psychiatry offered to third-year pharmacy students, which incorporates the viewing of movies and reading of books related to psychiatric illness, in order to allow students to develop a working knowledge of basic and advanced therapeutic issues related to psychiatry and psychopharmacology.

Download PDF

Advanced practice pharmacy experiences (APPE) in psychiatric pharmacy

PharmD, BCPP

DOI: 10.9740/mhc.n143599

Advanced practice pharmacy experiences (APPEs) are the foundations upon which pharmacy students develop the skills to apply the knowledge gained from their didactic courses. This article describes the APPEs in psychiatric pharmacy that are offered at the Purdue University College of Pharmacy.

Download PDF

Teaching and engaging students in large classes

PharmD, BCPP

DOI: 10.9740/mhc.n143601

Teaching large classes can be a challenge, especially if you are doing this for the first time. This article addresses how to approach teaching large classes and provides some strategies for promoting student engagement to facilitate learning.

Download PDF

Development of a collaborative psychiatric advanced pharmacy practice experience

PharmD, BCPP,

PharmD, BCPP, and

PharmD, BCPP

DOI: 10.9740/mhc.n144026

Introduction: Faculty are required to balance multiple duties, including, but not limited to teaching, precepting, and scholarly activity. Likewise, pharmacy managers with faculty appointments are challenged with balancing teaching and administrative duties. With increasing numbers of pharmacy students enrolled in colleges of pharmacy and the recent economic decline, there are concerns that increased responsibilities of faculty and preceptors may lead to sub-optimal advanced pharmacy practice experiences (APPEs).

Objectives: Describe a collaborate approach in teaching a psychiatric APPE allowing for additional time for other responsibilities while providing a favorable environment for students.

Methods: Pharmacy faculty and managers developed a collaborative psychiatric APPE. The pharmacists divided lectures and case discussions. Students were given many responsibilities (e.g., counseling, intervention documentation). Preceptor evaluations were documented and evaluated.

Results: Sixty-four students were precepted over two years. Student evaluations of APPE preceptors averaged 3.74/4.00. Additionally, faculty and pharmacy managers accomplished other activities.

Conclusion: It appears this collaborative team taught approach succeeded in providing an auspicious environment for students while allowing preceptors to be productive.

Download PDF

Occupational methamphetamine manufacturing toxin exposure: An exposure example

PharmD Candidate,

DO,

RN, MS, and

PharmD, MS, BCPP, CGP

DOI: 10.9740/mhc.n143928

Purpose

To illustrate opportunities for pharmacists as resources for community-based healthcare professionals that may be at-risk for occupational exposure to toxins of illicit methamphetamine (METH) manufacturing while providing case management services to community-based patients.

Summary

Pharmacists can serve as a resource with education and protocol development for minimizing the hazards of healthcare professionals, including pharmacists, at-risk for exposure to the toxins of METH manufacturing while providing community-based case management. The illicit production of METH requires solvents for extraction and purification and often results in the release of a number of harmful, and potentially deadly, chemicals and gases. For community-based healthcare professionals, risk factors include direct contact and inhalation. Community-based healthcare professionals providing case management services to patients involved in the production of METH are at-risk for exposure. Examples of an occupational exposure and how the pharmacist can serve as a resource to these providers are provided.

Conclusions

When conducting home- or community-based services, healthcare professionals may inadvertently experience health-related consequences and injuries because of exposure to hazardous wastes created by and used in the production of METH. The pharmacist can provide education and protocol development to help healthcare professionals identify hazards of exposure to the toxins of the manufacturing of METH, identify signs and symptoms of METH use, and identify signs and symptoms of toxin exposure.

Download PDF

Book Review: Uppers downers all arounders: Physical and mental effects of psychoactive drugs

PharmD, BCPP

DOI: 10.9740/mhc.n142070

CPNP members maintain a suggested reading list to provide information on peer recommended resources and convenient access to the highest quality neuropsychopharmacology publications. A reminder that if you shop with CPNP, by following the links below to Amazon, a small commission will be paid to CPNP which helps to financially support our mission to improve the minds and lives of individuals with psychiatric and/or neurologic disorders.

You can help grow this list of resources by suggesting a book.

Book: Uppers Downers All Arounders: Physical and Mental Effects of Psychoactive Drugs

From the publisher

The 7

Download PDF

Medication in the movies, Silver Linings Playbook: Views from two student groups

Student Group 1,

PharmD, BCPP,

Student Group 2,

, and

DOI: 10.9740/mhc.n143900

REVIEW FROM STUDENT GROUP 1

The opening scenes of the Silver Linings Playbook view like a trailer with a rapid sequence of events. The protagonist, Pat, a high school teacher, has been admitted to a psychiatric inpatient facility which the viewer later finds out is due to a violent outburst when he finds his wife, also a high school instructor, in the shower with another man. While at the inpatient facility, Pat attends regular group session therapy and is administered medication which he promptly spits out of his mouth. After receiving eight months of inpatient treatment, Pat's mother

Download PDF

Pursuing provider status

DOI: 10.9740/mhc.n144540

This month, I'm taking the opportunity to share with you, the progress CPNP has made in our Government Affairs efforts. Approximately 1 year ago, CPNP made a decision to increase its government affairs efforts with focus on obtaining provider recognition for clinical pharmacists.

Many of you have seen the press releases from CPNP and ACCP describing our partnership to advocate for and pursue “recognition for the direct patient care services of qualified clinical pharmacists as a covered benefit under the Medicare program …. The initiative promotes and advocates for comprehensive medication management as part of

Download PDF

CPNP Announcements

DOI: 10.9740/mhc.n143087

DIGGING DATA FOR A HEALTHIER WORLD

The closing keynote address at the 2013 CPNP Annual Meeting on Wednesday, April 24 will be presented by nationally recognized Dr. Atul Butte. We have accumulated several resources to provide you a taste of how Dr. Butte applies tools that convert more than 300 billion points of molecular, clinical, and epidemiological data -- measured by researchers and clinicians over the past decade -- into diagnostics, therapeutics, and new insights into disease.

Atul Butte, MD, PhD, the closing keynote speaker at the 2013 CPNP Annual Meeting on April 24 in Colorado

Download PDF

Pharmacist graduation competencies in a transformed healthcare market – Implications for psychiatric pharmacy

Toolbox: Tips for writing multiple choice questions

Movies and mental illness: A psychiatry elective for third year pharmacy students

Advanced practice pharmacy experiences (APPE) in psychiatric pharmacy

Teaching and engaging students in large classes

Development of a collaborative psychiatric advanced pharmacy practice experience

Occupational methamphetamine manufacturing toxin exposure: An exposure example

Book Review: Uppers downers all arounders: Physical and mental effects of psychoactive drugs

From the publisher

Medication in the movies, Silver Linings Playbook: Views from two student groups

REVIEW FROM STUDENT GROUP 1

Pursuing provider status

CPNP Announcements

DIGGING DATA FOR A HEALTHIER WORLD

Pharmacist administration of long-acting injectable medications for substance use disorders: A scoping review

Transitions of care: Assessment of adherence to long-acting injectable antipsychotic treatment following discharge from inpatient psychiatry

Use of atypical antipsychotics in individuals with anorexia nervosa

Potential changes impacting psychiatric pharmacy by 2030

A model for timely dissemination of critical information: Clozapine toxicity during the COVID pandemic